Concomitant administration of survivin suppressants and MAO-A inhibitors significantly mitigated tumor cell growth and migration and counteracted cancer metastasis by decreasing the level of the extracellular matrix digestion enzyme MMP-9 [41]. Here, MAOA is linked to neoplasm.